Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jonathan Oh"'
Autor:
Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100740- (2021)
Externí odkaz:
https://doaj.org/article/d3baaded57ca4fd4a1e40a9521b07521
Autor:
Ernest Bognar, Jonathan Oh, Meghan Manley, Neil Senzer, Rodney P. Rocconi, Luisa Manning, Gladice Wallraven, Staci Horvath, John Nemunaitis, Laura Stanbery, Minal A. Barve, Adam Walter, Phylicia Aaron
Publikováno v:
Gynecol Oncol Rep
Gynecologic Oncology Reports, Vol 36, Iss, Pp 100740-(2021)
Gynecologic Oncology Reports, Vol 36, Iss, Pp 100740-(2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df6d0946b3ff6d95c3afdb1bcb85318a
https://europepmc.org/articles/PMC8169695/
https://europepmc.org/articles/PMC8169695/
Autor:
Bradley J. Monk, Devansu Tewari, Erin E. Stevens, Gladice Wallraven, John Nemunaitis, Luisa Manning, Jonathan Oh, Rodney P. Rocconi, John K. Chan, Sharad A. Ghamande, Justin N. Bottsford-Miller, Peter C. Morris, Thomas J. Herzog, Elizabeth A. Grosen, Phylicia Aaron, Ernest Bognar, Min Tang, Minal A. Barve, Brian M. Slomovitz, Robert L. Coleman, Vigil Team
Publikováno v:
Journal of Clinical Oncology. 38:6017-6017
6017 Background: Vigil is an autologous tumor cell vaccine constructed from autologous harvested tumor tissue transfected with a DNA plasmid encoding GMCSF and bi-shRNA-furin thereby creating TGFβ expression control. Methods: A randomized double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d57902b9f63973509d4beb8cad19d60
https://doi.org/10.1200/jco.2020.38.15_suppl.6017
https://doi.org/10.1200/jco.2020.38.15_suppl.6017
Autor:
Jonathan Oh, Zhan Chen, Joerg Lahann, Kenneth Cheng, Hakan Durmaz, Xiaopei Deng, Yuwei Liu, Aftin M. Ross
Publikováno v:
Langmuir. 31:5123-5129
We use chemical vapor deposition polymerization to prepare a novel dibromomaleimide-functionalized polymer for selective and reversible binding of thiol-containing biomolecules on a broad range of substrates. We report the synthesis and CVD polymeriz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7d24dfa175943832186152e6de49b3
https://doi.org/10.1021/acs.langmuir.5b00654
https://doi.org/10.1021/acs.langmuir.5b00654
Autor:
Aftin M. Ross, Paul H. Krebsbach, Michael P. Hoepfner, Yaseen Elkasabi, Joerg Lahann, H. Scott Fogler, Jonathan Oh
Publikováno v:
Chemical Vapor Deposition. 20:23-31
A new method for generating and modeling reduced-scale copolymer gradients by CVD is reported. By exploiting diffusion through confined channels, functionalized [2.2]paracyclophanes are copolymerized into their poly(p-xylylene) (PPX) analogues as a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8de1cd593de06cb2e0e8b11350bb72c7
https://doi.org/10.1002/cvde.201307057
https://doi.org/10.1002/cvde.201307057
Autor:
Beena O. Pappen, Bruce Fine, Ned Adams, Elizabeth A. Grosen, E. Colin Koon, Jonathan Oh, Minal A. Barve, Ernest Bognar, Evelyn Fleming, Kenneth C. Hancock, Melanie K. Bergman, Gladice Wallraven, Leslie R. DeMars, Loyd West, John Nemunaitis, Neil Senzer, Thomas P. Heffernan, Howard M. Goodman, Carolyn M. Matthews, Padmasini Kumar, Luisa Manning, Daniel L. Spitz
Publikováno v:
Gynecologic oncology. 143(3)
Objectives The majority of women with Stage III/IV ovarian cancer who achieve clinical complete response with frontline standard of care will relapse within 2years. Vigil immunotherapy, a GMCSF/bi-shRNA furin DNA engineered autologous tumor cell (EAT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e84105a43446d8d15fbd5a1cd465ad
https://pubmed.ncbi.nlm.nih.gov/27678295
https://pubmed.ncbi.nlm.nih.gov/27678295
Autor:
Gladice Wallraven, John Nemunaitis, Susan W Mill, Cynthia Bedell, F. Charles Brunicardi, Phillip B. Maples, Zhaohui Wang, Donald Rao, Jonathan Oh, Beena O. Pappen, Connor Phalon, David M. Shanahan, Minal A. Barve, Chris M. Jay, Nicolas Taquet, Mitchell Magee, Anton Melnyk, Candice Higgs, Padmasini Kumar, Samuel Lifshitz, Fabienne Norvell, Peter Beitsch, Neil Senzer, Martin Lazar, Joseph A. Kuhn, Yang Yu
Publikováno v:
Molecular Therapy. 20:679-686
We performed a phase I trial of FANG vaccine, an autologous tumor-based product incorporating a plasmid encoding granulocyte-macrophage colony-stimulating factor (GMCSF) and a novel bifunctional short hairpin RNAi (bi-shRNAi) targeting furin converta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dce870238057832f22023eaa93bc382
https://doi.org/10.1038/mt.2011.269
https://doi.org/10.1038/mt.2011.269
Autor:
Robert L. Coleman, Devansu Tewari, Minal A. Barve, Elizabeth A. Grosen, Gladice Wallraven, John Nemunaitis, Rodney P. Rocconi, Jonathan Oh, Luisa Manning, Leslie R. DeMars, Martin Birkhofer, Erin E. Stevens, Neil Senzer, John K. Chan, Sharad A. Ghamande
Publikováno v:
Journal of Clinical Oncology. 35:TPS5604-TPS5604
TPS5604 Background: Vigil is an immuno-stimulatory autologous cellular therapy, which uses patient tumor cells transfected with a plasmid encoding genes for GM-CSF and furin (to down regulate TGFβ 1&2). In Phase I, systemic immune activation was dem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35486ba88fb76062e0a75eedb941ad01
https://doi.org/10.1200/jco.2017.35.15_suppl.tps5604
https://doi.org/10.1200/jco.2017.35.15_suppl.tps5604
Autor:
Evelyn Fleming, C.A. Stringer, Neil Senzer, T.P. Heffernan, Elizabeth A. Grosen, Carolyn M. Matthews, E.C. Koon, Howard M. Goodman, Minal A. Barve, M.S. Bergman, John Nemunaitis, Jonathan Oh, B.A. Fine, Leslie R. DeMars
Publikováno v:
Gynecologic Oncology. 137:2-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0227c5abbc8548754489510c3eb58b8
https://doi.org/10.1016/j.ygyno.2015.01.003
https://doi.org/10.1016/j.ygyno.2015.01.003
Autor:
Neil Senzer, Joseph A. Kuhn, Peter D. Beitsch, Anton Melnyk, Phillip B. Maples, Gladice Wallraven, Jonathan Oh, John Nemunaitis, Minal A. Barve, Beena O. Pappen, Donald Rao, Mitchell Magee, Cynthia Bedell, Padmasini Kumar, Jacklyn Nemunaitis, Charles Brunicardi F
Publikováno v:
Journal of Vaccines & Vaccination.
Study Background: Previously, we demonstrated safety and correlated induced immune response with survival in a Phase I study of FANG immunotherapy in advanced cancer patients. We now report long term follow-up (FU) of Phase I treated patients includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a94765a263f5ff3bd859d5658144dd64
https://doi.org/10.4172/2157-7560.1000209
https://doi.org/10.4172/2157-7560.1000209